About Forel Labs
Forel Labs is a company based in Visakhapatnam (India) by Dileep Bayyana. It operates as a B2B and Manufacturing. The company has 3 employees. Forel Labs offers products and services including Generic APIs and Bulk Drugs. Forel Labs operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Visakhapatnam, India
- Employees 3
- Founders Dileep Bayyana
- SectorsHealthcare
- Email••••••••
- Website forellabs.com
- Legal Name Forel Labs Private Limited
- Date of Incorporation 04 May, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹2.05 Cr
FY 2024 · -87% YoY
- Net Loss-₹2.9 Lakh
FY 2024 · -1% margin
- EBITDA-₹93,759
FY 2024 · 0% margin
- Employee Count3
Associated legal entities of Forel Labs
Forel Labs operates through Forel Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Forel Labs Private Limited CIN U24232TG2011PTC074271 | Active | 04 May 2011 | Hyderabad, Telangana | ₹2.1 Cr | 3 | 2 | View details |
Products & Services of Forel Labs
Forel Labs offers a comprehensive portfolio of products and services, including Generic APIs and Bulk Drugs.
Manufacture of generic active ingredients for various therapies
Production of bulk pharmaceutical substances for global markets
Board of directors of Forel Labs Private Limited (Forel Labs)
Forel Labs Private Limited is the primary company behind Forel Labs. The board of Forel Labs Private Limited currently have 2 directors; the longest-serving is Kotte Veera Venkateswara Rao, appointed in 2011. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kotte Veera Venkateswara Rao DIN 03393308 | Director | 04 May 2011 | 15 yrs 5 mo | Forel Labs Private Limited |
| Siva Rama Krishna Prasad Kodeboyina DIN 05179156 | Managing Director | 10 Mar 2018 | 8 yrs 7 mo | Forel Labs Private Limited |
People of Forel Labs
1 people are tracked at Forel Labs (1 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
| Founder, MD | Leadership |
Complete people profiles for Forel Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Forel Labs
Figures of Forel Labs Private Limited, the primary company behind Forel Labs, for FY 2024. Revenue was ₹2.05 Cr (-87% year on year). Net loss was -₹2.9 Lakh (-1% margin). EBITDA was -₹93,759 (0% margin). Revenue has grown at a compounded annual rate of -47% over three years and -24% over five years.
- ₹2.05 CrRevenue · FY 2024 · -87% YoY
- -₹2.9 LakhNet loss · -1% margin
- -₹93,759EBITDA · 0% margin
- ₹15.00 CrPaid-up capital
- 3Employees (provident fund records)
- -47%Revenue CAGR, 3 years
- -24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Forel Labs Private Limited are on its company page.
Detailed financial statements for Forel Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Forel Labs
Forel Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Forel Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Forel Labs
10 companies that operate in the same segment as Forel Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Forel Labs
Forel Labs is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
Forel Labs has 3 employees.
The primary company behind Forel Labs, Forel Labs Private Limited, reported revenue of ₹2.05 Cr for FY 2024, down 87% year on year.
Forellabs is a bulk drug manufacturer specializing in generic active pharmaceutical ingredients across various therapeutic domains. They focus on quality management and assurance to meet regulatory standards like FDA approval. The company operates from manufacturing sites in Visakhapatnam and corporate offices in Hyderabad, India, with a USA office for global reach. They serve clients through expertise in bulk drug production and market networks.
Forel Labs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Forel Labs offers Generic APIs and Bulk Drugs.
Forel Labs operates through Forel Labs Private Limited.
The legal entities of Forel Labs currently have 2 directors, including Siva Rama Krishna Prasad Kodeboyina, Kotte Veera Venkateswara Rao.